Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial.
Tavenier AH, Hermanides RS, Ottervanger JP, Rasoul S, Slingerland RJ, Tolsma R, van Workum S, Kedhi E, van 't Hof AWJ. Tavenier AH, et al. Among authors: ottervanger jp. Neth Heart J. 2019 Apr;27(4):185-190. doi: 10.1007/s12471-019-1241-6. Neth Heart J. 2019. PMID: 30767166 Free PMC article.
High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial.
Hermanides RS, Heestermans AA, Ten Berg JM, Gosselink AT, Ottervanger JP, van Houwelingen KG, Kolkman JJ, Stella PR, Dill T, Hamm C, van 't Hof AW. Hermanides RS, et al. Among authors: ottervanger jp. Heart. 2011 Jan;97(2):106-11. doi: 10.1136/hrt.2010.194951. Epub 2010 Oct 20. Heart. 2011. PMID: 20962338 Clinical Trial.
A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI: Insights from the Zwolle acute myocardial infarction registry.
Heestermans AA, Hermanides RS, Gosselink AT, de Boer MJ, Hoorntje JC, Suryapranata H, Ottervanger JP, Dambrink JH, Kolkman E, Ten Berg JM, Zijlstra F, van 't Hof AW. Heestermans AA, et al. Among authors: ottervanger jp. Neth Heart J. 2010 Dec;18(12):592-7. doi: 10.1007/s12471-010-0840-z. Neth Heart J. 2010. PMID: 21301621 Free PMC article.
Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance.
Beukema RJ, Elvan A, Ottervanger JP, de Boer MJ, Hoorntje JC, Suryapranata H, Dambrink JH, Gosselink AT, van 't Hof AW; Zwolle Myocardial Infarction Study Group. Beukema RJ, et al. Among authors: ottervanger jp. Neth Heart J. 2012 Apr;20(4):155-60. doi: 10.1007/s12471-012-0242-5. Neth Heart J. 2012. PMID: 22359247 Free PMC article.
The extent of ST elevation and ST deviation as predictors of mortality in ST-segment elevation myocardial patients planned to undergo primary percutaneous coronary intervention.
Postma S, Dambrink JHE, Gosselink ATM, Ottervanger JP, Kolkman E, Ten Berg JM, Suryapranata H, Van't Hof AWJ. Postma S, et al. Among authors: ottervanger jp. Int J Cardiol. 2016 Feb 15;205:31-36. doi: 10.1016/j.ijcard.2015.11.177. Epub 2015 Nov 28. Int J Cardiol. 2016. PMID: 26709137
Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a 'real world' prospective registry.
Badings EA, Hermanides RS, Van Der Sluis A, Dambrink JHE, Gosselink ATM, Kedhi E, Ottervanger JP, Roolvink V, Remkes WS, Van't Riet E, Suryapranata H, Van't Hof AWJ. Badings EA, et al. Among authors: ottervanger jp. Neth Heart J. 2019 Feb;27(2):73-80. doi: 10.1007/s12471-018-1212-3. Neth Heart J. 2019. PMID: 30547413 Free PMC article.
325 results